Detalhe da pesquisa
1.
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
; 68(4): e28833, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336845
2.
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
Pediatr Blood Cancer
; 68(4): e28879, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405376
3.
Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
Mol Biol Rep
; 48(11): 7537-7544, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643931
4.
Benign skull and subdural lesions in patients with prior medulloblastoma therapy.
Childs Nerv Syst
; 37(2): 359-366, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32876801
5.
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 21(6): e317-e329, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502458
6.
Symptom burden trajectories experienced by patients with brain tumors.
Cancer
; 126(14): 3341-3351, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374469
7.
A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
J Neurooncol
; 149(3): 437-445, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33040274
8.
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Lancet Oncol
; 20(7): 1011-1022, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151904
9.
Using the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure symptom burden reported by patients with brain tumors.
Pediatr Blood Cancer
; 66(3): e27526, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426667
10.
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.
J Neurooncol
; 136(3): 475-484, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29170909
11.
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.
Pediatr Blood Cancer
; 65(9): e27217, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750396
12.
Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors.
Qual Life Res
; 26(9): 2541-2550, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447250
13.
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
J Neurooncol
; 127(1): 53-61, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626490
14.
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
J Neurooncol
; 129(3): 443-451, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27350411
15.
A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients.
Childs Nerv Syst
; 32(3): 475-83, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26812488
16.
Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases.
J Neurooncol
; 122(1): 105-10, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25502962
17.
Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.
J Neurooncol
; 121(3): 591-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433556
18.
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.
J Neurooncol
; 121(1): 217-24, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407389
19.
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).
J Neurooncol
; 123(1): 85-91, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25859842
20.
A patient-centered symptom monitoring and reporting system for children and young adults with cancer (SyMon-SAYS).
Pediatr Blood Cancer
; 62(10): 1813-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25856587